08 Oct 2020 --- The COVID-19 pandemic has had both positive and negative impacts on Chr. Hansen’s 2019/2020 financial results, which overall saw 5 percent organic growth with revenues boosted to €1.189 billion (US$1.396 billion). Executive vice president and CFO Søren Lonning speaks to NutritionInsight about moves for infant nutrition, probiotics and “taking a breather” following a string of acquisitions.
